Posts in category Healthcare


ODAC Supports Puma Biotechnology Inc’s (PBYI) Neratinib, J.P. Morgan Cheers

In a 12-4 vote, the FDA’s Oncologic Drugs Advisory Committee (ODAC) supported the approval of Puma Biotechnology …

Read more

Inovio Pharmaceuticals Inc (INO) Moves a Step Closer to an HIV Vaccine; Maxim Lifts Price Target

Inovio Pharmaceuticals Inc (NASDAQ:INO) rose over 20% in Wednesday’s trading session, after the drug maker …

Read more

Puma Biotechnology Inc (PBYI): Positive Risk/Reward Ahead of ODAC Meeting

It is a good day to be a Puma Biotechnology Inc (NASDAQ:PBYI) investors, with shares …

Read more

GlycoMimetics Inc (GLYC) Shares Continue Fast Rally on Back of Promising Early Data in AML

What does GlycoMimetics Inc’s (NASDAQ:GLYC) abstract data for the American Society for Clinical Oncology (ASCO) …

Read more

H.C. Wainwright Cuts Price Taget for Aurinia Pharmaceuticals Inc (AUPH) To Reflect Recent Share Dilution and Financial Overhang

Yesterday, drug maker Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) announced the beginning of Phase 3 trial AURORA …

Read more

Cowen Encouraged About Syndax Pharmaceuticals Inc’s (SNDX) Positive Data Readouts in NSCLC

Syndax Pharmaceuticals Inc (NASDAQ:SNDX) announced yesterday that the ENCORE 601 non-small cell lung cancer (NSCLC) …

Read more

Canaccord Pounds The Table On Palatin Technologies, Inc. (PTN)

Canaccord analyst John Newman was out pounding the table on shares of Palatin Technologies, Inc.(NYSEMKT:PTN), reiterating …

Read more

Sophiris Bio Inc (SPHS): Phase 2b Trial One Step a Way to Take Off

Drug maker Sophiris Bio Inc (NASDAQ:SPHS) released its earnings report for the first quarter of 2017 …

Read more

Akebia Therapeutics Inc (AKBA) Shares Soar on Partnership Deal; Top Analyst Lifts Price Target

Akebia Therapeutics Inc (NASDAQ:AKBA) shares are soaring over 15% as of this writing, after the …

Read more

Synergy Pharmaceuticals Inc (SGYP) Gains Upper Hand in IBS-C Arena

Believing Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) odds in the IBS-C competitive arena just got better, Rodman …

Read more